Summary

Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.

Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.

Some prices, such as Merck’s diabetes drugs, will be reduced.

Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.

  • @Landless2029
    link
    385 days ago

    Its almost like dragons and thier hoards. Just keep piling it up…

    But they’re not magestic like dragons. Still close… Lizard people? Cold blooded. Predatory. It tracks.

    • @[email protected]
      link
      fedilink
      English
      85 days ago

      Somebody did the math already; Bezos alone has more money than is depicted in Smaugs hoard in The Hobbit

    • @blazeknave
      link
      15 days ago

      Huh. Wonder if that’s where the Icke stuff comes from. A line drawn from dragons.